Our website uses cookies to enhance your browsing experience and to collect information about how you use this site to improve our service to you. By not accepting cookies some elements of the site, such as video, will not work. Please visit our Cookie Policy page for more information on how we use cookies.

Janssen Sciences Adding 200 Jobs In Ringaskiddy

Janssen Sciences is to invest €300m to expand its factory at Ringaskiddy, Co Cork and to add 200 more staff to its existing employment roll of 555.

The expansion. part funded by taxpayers through payments from IDA Ireland, will add 19,100 sq m to the existing plant, and will employ 450  people during construction.

Vice president Remo Colarusso said: “This expansion will increase Janssen’s global manufacturing capacity of biologic medicines, which is in keeping with our Credo commitment to provide the highest quality products to patients. Our Ringaskiddy site is an important part of Janssen’s global manufacturing network and this expansion will allow us to grow in a location that offers advanced infrastructure, a high-performance culture and top-level talent.” 

Janssen Sciences has operated a biopharmaceutical factory on its 40 hectare site in Ringaskiddy since 2005, manufacturing products for the treatment of conditions such as rheumatoid arthritis, psoriasis and cancer. 

The expansion, which will  commence this month and will take two years to complete, includes:

Construction of a new manufacturing building

  • Expansion of the existing warehouse building, laboratory and administration buildings.
  • Modification to the existing site and infrastructure, including utilities, car parking, underground services, internal roads, yards and pipe racks.
  • Expansion of the on-site waste water treatment plant to accommodate increased volumes. 

Janssen Sciences Ireland, previously called Janssen Biologics, is part of Johnson & Johnson, which employ in excess of 2,700 people in Ireland. The employees support the company’s pharmaceutical, medical device and consumer business through engineering, manufacturing, quality, sales and marketing, commercial and IT roles.

J&J operates 11 sites in Ireland in Cork, Dublin and Limerick. The overall operation comprises six manufacturing plants, four commercial offices and an IT centre of excellence.

Janssen made the announcement despite some American peer multinationals recently deciding not to publicise their IDA grant-aided projects so as to stay off Donald Trump’s radar.